NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/02/2026
Back to search
Official data from USPTO
ENTASIS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/21/2026
Classification
Registered
Trademark type
Combined
Nice classes
5, 10, 42, 44
Filing date
12/14/2017
Registration date
07/23/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Waltham, MA, US
Examiner
BELLO, ZACK
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a geometric design resembling a stylized letter "E" and its mirror image, which appears to the left of the word "ENTASIS" in stylized print, which appears directly above the word "THERAPEUTICS" in smaller stylized print.
Holders and representatives
Holders
ENTASIS THERAPEUTICS INC.
Entasis Therapeutics, Ltd.
Representatives
Keith Toms MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti-infectives and antibiotics ; dietetic food and substances adapted for medical use; dietary supplements for humans
Class 10
Surgicalmedical and dental apparatus and instruments for medical use; artificial limbseyesteeth; orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials
Class 42
Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticalsdrugs and antibiotics; conducting clinical trials for others; informationadvisory and consultancy services in relation to the aforesaid services
Class 44
Medical services; advisory services relating to healthcare; providing information in the fields of healthmedicinepharmaceuticals for medical diagnostic and treatment purposes; medical information servicesproviding medical and treatment information to physicianshealthcare professionals and patients on the topics of health issuestherapies associated with pharmaceutical productshealth awareness; informationadvisory and consultancy services in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
40 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
04/02/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/23/2026
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
03/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES8R
TEAS SECTION 8 RECEIVED
10/06/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/14/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/23/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/22/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/22/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/22/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/21/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/21/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2018
GNRT
NON-FINAL ACTION E-MAILED
11/15/2018
CNRT
NON-FINAL ACTION WRITTEN
11/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2018
ALIE
ASSIGNED TO LIE
10/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/24/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2018
GNRT
NON-FINAL ACTION E-MAILED
03/27/2018
CNRT
NON-FINAL ACTION WRITTEN
03/27/2018
DOCK
ASSIGNED TO EXAMINER
03/26/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/29/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2017
NWAP
NEW APPLICATION ENTERED
12/18/2017
Continuous trademark protection
Get notified about every new filing that threatens ENTASIS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.